Cosmax BTI, Inc. cancelled the acquisition of 56.5% stake in Twowin Pharma Co.,Ltd.
April 26, 2019
Share
Cosmax BTI, Inc. (KOSE:A044820) agreed to acquire 56.5% stake in Twowin Pharma Co.,Ltd on April 27, 2018. Cosmax BTI, Inc. will acquire 4.99 million shares of Twowin Pharma Co.,Ltd. Twowin Pharma Co.,Ltd reported total assets of KRW 19.52 billion and total capital of KRW 762 million as at December 31, 2017. The Board of Directors passed a resolution for the transaction on April 27, 2018.
Cosmax BTI, Inc. (KOSE:A044820) cancelled the acquisition of 56.5% stake in Twowin Pharma Co.,Ltd on April 27, 2019.
COSMAXBTI, INC. is a Korea-based company mainly engaged in manufacturing cosmetics. Through its subsidiaries in China, Indonesia and the United Sates, the Company operates its business through three segments: cosmetics segment, which produces cosmetics such as skin care, make-up, hair care and functional cosmetics; healthy food segment, which produces vitamins and diet drugs, and other segment, which produces cosmetics and plastic pumps. The Company distributes its products within domestic market and to overseas markets.